 Cannabinoid-focused biotech company Anebulo Pharmaceuticals, Inc. NASDAQ:ANEB announced its financial results Wednesday for the three and 12 months ended June 30. Over the fourth quarter of fiscal 2021, the Austin, Texas-based company closed an initial public offering of its 3.08 million shares of common stoke at 7 million, for gross proceeds of 21.5 million. 